Results 181 to 190 of about 86,511 (262)

Acceptable Nomenclature for Pregnancy Loss Care: A Cross‐Sectional Observational Survey

open access: yesBJOG: An International Journal of Obstetrics &Gynaecology, Volume 133, Issue 3, Page 471-479, February 2026.
ABSTRACT Objective To conduct a pilot study evaluating the acceptability of pregnancy loss nomenclature among people with recent lived experience and make recommendations for UK mass communication. Design Electronic internet‐based questionnaire. Setting UK. Population or Sample Service users who accessed UK healthcare for > 1 experience(s) of pregnancy
Beth Malory   +2 more
wiley   +1 more source

The Secretome of Human Trophoblast Stem Cells Attenuates Senescence‐Associated Traits

open access: yesAging Cell, Volume 25, Issue 2, February 2026.
Human trophoblast stem cell‐derived secretome/conditioned medium (hTSC‐CM) and the extracellular vesicles (EVs) therein suppress DNA damage and NF‐κB activation in senescent fibroblasts, in turn reducing the production of senescence‐associated secretory phenotype (SASP) factors. This study highlights hTSC‐CM and EVs as potential senotherapeutic agents.
Kotb Abdelmohsen   +18 more
wiley   +1 more source

The threshold of estradiol level for fresh embryo transfer differs between blastocyst and cleavage‐stage embryo

open access: yesActa Obstetricia et Gynecologica Scandinavica, Volume 105, Issue 2, Page 257-267, February 2026.
Our results suggested that the difference in pregnancy outcomes between fresh and frozen embryo transfer is related to the peak estradiol level and embryo transfer stage. The cutoff values for peak estradiol level for performing freeze‐all strategy to improve pregnancy outcomes were different for cleavage‐stage and blastocyst‐stage embryo transfer ...
Dingying Zhao   +12 more
wiley   +1 more source

TUBAL ECTOPIC PREGNANCY [PDF]

open access: yesObstetrical & Gynecological Survey, 1963
openaire   +2 more sources

Impact of anti‐VEGF therapy versus laser therapy on mortality and treatment outcomes in retinopathy of prematurity: A systematic review and meta‐analysis

open access: yesActa Ophthalmologica, Volume 104, Issue 1, Page e1-e17, February 2026.
Abstract Purpose Retinopathy of prematurity (ROP) is a major cause of childhood blindness, and selecting the optimal treatment between anti‐vascular endothelial growth factor (anti‐VEGF) and laser therapy is crucial. Understanding their impact on key outcomes, particularly mortality, is essential for informed clinical decision‐making.
Wei‐De Wang   +10 more
wiley   +1 more source

Home - About - Disclaimer - Privacy